ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,040.04
1.10%
Dow Jones
43,297.03
0.91%
US Dollar vs MXN
20.1749
-0.05%
Brent Oil
73.285
0.80%
Bitcoin
97,940.71
3.43%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Oruka Therapeutics Inc (ORKA) Cotización

Oruka Therapeutics Inc

Oruka Therapeutics Inc (ORKA)

NASDAQ
21.13
0.13
( 0.62% )
Actualizado: 12:42:14
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
21.13
Postura de Compra
20.50
Postura de Venta
21.13
Volume Operado de la Acción
240,572
20.50 Rango del Día 21.67
18.20 Rango de 52 semanas 31.13
Precio Anterior
21.00
Precio de Apertura
20.86
Hora
5325
@
21.13
Última hora de negociación
12:00:00
Volumen promedio (3 m)
225,037
Volumen financiero
US$ 5,058,237
Precio Promedio Ponderado
21.0259

ORKA Últimas noticias

Más noticias

Form 8-K - Current report

19 Diciembre 2024
Edgar (US Regulatory)

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody

Pharmacokinetic and safety data from healthy volunteers anticipated in the second half of 2025 On track to initiate a proof-of-concept study in psoriasis in the second half of 2025, with initial...

19 Diciembre 2024
GlobeNewswire Inc.

Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)

MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the...

18 Diciembre 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

26 Noviembre 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

21 Noviembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

21 Noviembre 2024
Edgar (US Regulatory)

Oruka Therapeutics to Present at Piper Sandler’s 36th Annual Healthcare Conference

MENLO PARK, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the...

19 Noviembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

18 Noviembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Noviembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Noviembre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-1.43-6.3386524822722.5623.5719.837593783720.86701703CS
42.6214.154511075118.5125.6518.239278221.35353838CS
12-3.63-14.660743134124.7631.1318.222503723.05172747CS
26-7.87-27.13793103452931.1318.218410723.19678156CS
52-7.87-27.13793103452931.1318.218410723.19678156CS
156-7.87-27.13793103452931.1318.218410723.19678156CS
260-7.87-27.13793103452931.1318.218410723.19678156CS

ORKA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Oruka Therapeutics?
El precio actual de las acciones de Oruka Therapeutics es US$ 21.13
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Oruka Therapeutics?
Oruka Therapeutics ha negociado en un rango de US$ 18.20 a US$ 31.13 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BAOSBaosheng Media Group Holdings Ltd
US$ 7.10
(310.40%)
58.49M
HOURHour Loop Inc
US$ 4.40
(207.69%)
97.14M
GTIGraphjet Technology
US$ 0.61
(168.72%)
264.29M
CREVCarbon Revolution Public Ltd
US$ 9.16
(135.48%)
26.85M
AVGRAvinger Inc
US$ 1.45
(125.72%)
107.18M
SLGLSol Gel Technologies Ltd
US$ 0.9798
(-40.62%)
3.03M
DRCTDirect Digital Holdings Inc
US$ 3.71
(-32.55%)
23.7M
CHEKCheck Cap Ltd
US$ 1.55
(-31.11%)
3.48M
SYTASiyata Mobile Inc
US$ 0.5178
(-30.83%)
2.54M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
US$ 15.47
(-30.38%)
147.54k
SVMHSRIVARU Holding Ltd
US$ 0.0338
(20.71%)
278.51M
GTIGraphjet Technology
US$ 0.61
(168.72%)
264.29M
LITMSnow Lake Resources Ltd
US$ 0.5849
(52.84%)
180.27M
LCIDLucid Group Inc
US$ 3.20
(3.23%)
108.14M
RGTIRigetti Computing Inc
US$ 11.35
(3.56%)
107.83M

Discusión

Ver feed completo
Monksdream Monksdream 3 minutos hace
Merry Christmas every body looking forward to a lucrative new year
sundoctor sundoctor 4 minutos hace
some update on TSOI website https://therapeuticsolutionsint.com/
TSOI
capgain capgain 4 minutos hace
Same to you and all. Have a good one :)
Yachtmaster Yachtmaster 5 minutos hace
The one thing that really validates this tech is you. Your our acknowledgment of this being the great white pipe in reducing viscosity and saving billions in costs to oil companies is appreciated….
Thank you for your support and Merry Christmas my little jolly sausage 🥰…
Merry
QSEP
mick mick 5 minutos hace
Some interestng views here \/ $CNRC

https://cunninghamnaturalresources.com/operations/

Operations
At Cunningham Natural Resources (CNR), our efforts span beyond North America,
with projects in Africa, South America, and Southeast Asia.
CNRC
mick mick 5 minutos hace
Some interestng views here \/ $CNRC

https://cunninghamnaturalresources.com/operations/

Operations
At Cunningham Natural Resources (CNR), our efforts span beyond North America,
with projects in Africa, South America, and Southeast Asia.
CNRC
fuagf fuagf 5 minutos hace
Thanks, good to know. Sure wish my teeth were as good as his, they weren't from birth. Burt had had a good life
i guess. There's a tidbit i can mention to others today. It's conversation which most likely won't upset anyone. lol
StockItOut StockItOut 6 minutos hace
Here's one more to get your story crumbling...

1.) you posted a link to an old old static Pace!Monitor link.

2.) you called me a liar.

3.) The SecuritiesLawyer101 article that references Xeriant's case represented by The Basile Law Firm, is a lie you say.
XERI
ignatiusrielly35 ignatiusrielly35 6 minutos hace
LOL. Yeah, now is the time to sell and move on. 
AVXL
capgain capgain 7 minutos hace
Very true lol.
Myth Myth 7 minutos hace
I Hear Thunder - Tab Benoit ( New )

https://www.youtube.com/watch?v=4a4z6rYhzWA
DAR53 DAR53 7 minutos hace
Well, I hope my fortune cookie comes true. "Good News! Something you have been waiting for will come true soon".
I wish all longs a very Merry Christmas and a Happy and Properous New Year for 2025.
GLTA
AMRN
OMOLIVES OMOLIVES 7 minutos hace
!! Anyone that is suggesting any individual retail shorting is happening needs to just drop it..and refer to the source:

FINRA Rule 4210
Regulation T
Regulatory Notice 11-16
Treatment of Non-Margin Eligible Equity Securities

https://www.finra.org/ru
HMBL
theorysuit theorysuit 7 minutos hace
I see all management's share gifts and sales are now in a table.

Items 1 - 80

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information
NWBO
IB_ IB_ 8 minutos hace
Which year, 👸 ?????????????????

$1.00 by the end of 2024 is BS time,

IB_🤴
ELTP
mailman69 mailman69 8 minutos hace
Happy holidays to everyone
VXIT
Myth Myth 8 minutos hace
that's how it is here, couple of in but roads clear...

Have a safe trip and enjoy !
mick mick 10 minutos hace
fishing \/ https://www.investing.com/equities/worldwide-internet
pos_stock_hoarder pos_stock_hoarder 11 minutos hace
It happened and the sun is out now. It'll stay white but the roads will be good. Traveling tonight to near High Point, NJ. As high up as you can go in this state. And, yes, they get a lot more snow than we do!

Enjoy your nog and the rest of the Christmas festivities. I drive up t
Myth Myth 11 minutos hace
thank you Cap, rolled around rather quickly don't ya think ?

gotta slow this down somehow...lol..
rmmc rmmc 11 minutos hace
OPEN COMMUNICATION TO THE NEW IR TEAM.
Someone suggested you do a webinar with live visits from the CEO, CFO and COO. answer a couple of questions and introduce yourselves. If you want to stop all falsehoods and fake X accounts maybe this would help. How about it? Tina I know you are watchin
HIRU
Stern is Bald Stern is Bald 11 minutos hace
None of the underlying causing w/ the subprime loans are here now...
FNMA
thistraderknowsall thistraderknowsall 11 minutos hace
BTC and GRAVITY G WOW Nice recovery!!
GRAVITY G also
Mooovin with GRAVITY G Protected to $1 today!
On AI Great news!! We win!!

Su Consulta Reciente

NASDAQ
ORKA
Oruka Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados